A NF-κB signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cells.
about
A NF-κB signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cells.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A NF-κB signature predicts low ...... on patient-derived stem cells.
@en
A NF-κB signature predicts low ...... on patient-derived stem cells.
@nl
type
label
A NF-κB signature predicts low ...... on patient-derived stem cells.
@en
A NF-κB signature predicts low ...... on patient-derived stem cells.
@nl
prefLabel
A NF-κB signature predicts low ...... on patient-derived stem cells.
@en
A NF-κB signature predicts low ...... on patient-derived stem cells.
@nl
P2093
P2860
P356
P1433
P1476
An NF-κB signature predicts lo ...... on patient-derived stem cells
@en
P2093
Andrea Zanello
Barbara Toffoletto
Carla Di Loreto
Cecilia Correcig
Damiano Mangoni
Enrico Pegolo
Evgenia Bourkoula
Federica Caponnetto
Ivana Manini
Laura Mariuzzi
P2860
P304
P356
10.1093/NEUONC/NOX234
P577
2018-05-01T00:00:00Z